Advertisement

Topics

"Central Venous Catheters Market Outlook 2023 Report Updated" Drugs and Medication Database

19:46 EDT 23rd September 2017 | BioPortfolio

Here are the most relevant "Central Venous Catheters Market Outlook 2023 Report Updated" Drugs and Medications that we have found in our database.

More Information about "Central Venous Catheters Market Outlook 2023 Report Updated" on BioPortfolio

We have published hundreds of Central Venous Catheters Market Outlook 2023 Report Updated news stories on BioPortfolio along with dozens of Central Venous Catheters Market Outlook 2023 Report Updated Clinical Trials and PubMed Articles about Central Venous Catheters Market Outlook 2023 Report Updated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Central Venous Catheters Market Outlook 2023 Report Updated Companies in our database. You can also find out about relevant Central Venous Catheters Market Outlook 2023 Report Updated Drugs and Medications on this site too.

Showing "Central Venous Catheters Market Outlook 2023 Report Updated" Drugs and Medications 1–25 of 174

ALB

Albutein [Grifols Biologicals Inc.]

These highlights do not include all the information needed to use Albutein 5% safely and effectively. See full prescribing information for Albutein 5%. Albutein 5% [Albumin (Human) U.S.P.] sterile, aqueous solution for single dose intravenous administra

Albutein [Grifols Biologicals Inc.]

These highlights do not include all the information needed to use Albutein 20% safely and effectively. See full prescribing information for Albutein 20%. Albutein 20% [Albumin (Human) U.S.P.] sterile, aqueous solution for single dose intravenous administ

AMI

Aminosyn [Hospira, Inc.]

AMINOSYN-HBC 7%

Aminosyn ii [Hospira, Inc.]

AMINOSYN II

Aminosyn ii [Hospira, Inc.]

Aminosyn II

Aminosyn ii [Hospira, Inc.]

Aminosyn IISulfite-Free

Aminosyn ii with electrolytes [Hospira, Inc.]

Aminosyn II 8.5% WITH ELECTROLYTESSulfite-Free

Aminosyn sulfite free [Hospira, Inc.]

Aminosyn 10% (pH 6)Sulfite-Free

Aminosyn-pf [Hospira, Inc.]

Aminosyn -PF 7%Sulfite-Free

Aminosyn-pf [Hospira, Inc.]

Aminosyn -PF 10%Sulfite-Free

AMY

Amyl nitrite [James Alexander Corporation]

Drug Facts

ANA

Anastrozole [Sun Pharmaceutical Industries Limited ]

These highlights do not include all the information needed to use anastrozole tablets safely and effectively. See full prescribing information for Anastrozole Tablets. Anastrozole tablet for oral useInitial U.S. Approval: 1995

Anastrozole [APP Pharmaceuticals, LLC]

These highlights do not include all the information needed to use Anastrozole Tablets safely and effectively. See full prescribing information for Anastrazole Tablets. Anastrozole Tablets for oral use Initial U.S. Approval: 1995

ARU

Aruba aloe lip sunscreen and moisturizer [Aruba Aloe Balm NV]

Aruba Aloe Lip Sunscreen and Moisturizer

ATE

Atenolol [State of Florida DOH Central Pharmacy]

Atenolol Tablets, USP

AVC

Avc vaginal [Azur Pharma Inc.]

AVC CREAM (sulfamilamide) 15%

BAB

Babor cleansing hy-ol [Babor Cosmetics America, Corp]

Cleansing insert

BAC

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Bacteriastatic sodium chloride [General Injectables & Vaccines, Inc.]

Bacteriostatic 0.9% Sodium Chloride 0.9% Injection, USP 30 mL Multi Dose Vial

BEN

Benztropine mesylate [Rebel Distributors Corp]

BENZTROPINE MESYLATE TABLETS USP0.5 mg, 1 mg and 2 mgRx only

Benztropine mesylate [Pliva Inc.]

BENZTROPINE MESYLATE TABLETS USP

Benztropine mesylate [UDL Laboratories, Inc.]

BENZTROPINE MESYLATE TABLETS, USP 0.5 mg, 1 mg and 2 mg

Benztropine mesylate [State of Florida DOH Central Pharmacy]

BENZTROPINE MESYLATE TABLETS USP0.5 mg, 1 mg and 2 mgRx only

Benztropine mesylate [Rising Pharmaceuticals Inc]

BENZTROPINE MESYLATE TABLETS USP0.5 mg, 1 mg and 2 mgRx only

Benztropine mesylate [American Health Packaging]

BENZTROPINE MESYLATE TABLETS



Quick Search
Advertisement